Metraipolis › archive › dc_42fb134119bd
[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies — Europe PMC PMID:42020146
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42020146
- DOI
- 10.2967/jnumed.125.271705
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:13:48.935Z
- SHA-256 of the archived text
2ceb2f17eea64140ff9711124d7f08be04a6c0e6159802404a6589b5ea525fdd- Stable URL of this page
https://metraipolis.com/documento/dc_42fb134119bd
How to cite
[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies — Europe PMC PMID:42020146 — Europe PMC (en), https://europepmc.org/article/MED/42020146 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42fb134119bd (Metraipolis archive dc_42fb134119bd, sha256 2ceb2f17eea64140ff9711124d7f08be04a6c0e6159802404a6589b5ea525fdd)
BibTeX
@misc{dc42fb134119bd,
title = {[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies — Europe PMC PMID:42020146},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42020146},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42fb134119bd; sha256 2ceb2f17eea64140ff9711124d7f08be04a6c0e6159802404a6589b5ea525fdd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42020146. Agents can read the archived copy with the MCP tool read_document.